Septerna

Septerna is a drug discovery company using a platform to target GPCRs. Its lead asset treats hypoparathyroidism by mimicking native receptor function.
Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2024
Stage of Initial Investment
Series B
Initial Investment Year
2023